astrazeneca finance limited
astrazeneca finance limited Company Information
Company Number
02761796
Next Accounts
Sep 2025
Shareholders
astrazeneca uk ltd
Group Structure
View All
Industry
Banks
+1Registered Address
1 francis crick avenue, cambridge biomedical campus, cambridge, CB2 0AA
Website
http://astrazneca.co.ukastrazeneca finance limited Estimated Valuation
Pomanda estimates the enterprise value of ASTRAZENECA FINANCE LIMITED at £0 based on a Turnover of £0 and 0.79x industry multiple (adjusted for size and gross margin).
astrazeneca finance limited Estimated Valuation
Pomanda estimates the enterprise value of ASTRAZENECA FINANCE LIMITED at £0 based on an EBITDA of £0 and a 3.96x industry multiple (adjusted for size and gross margin).
astrazeneca finance limited Estimated Valuation
Pomanda estimates the enterprise value of ASTRAZENECA FINANCE LIMITED at £212.9k based on Net Assets of £64.8k and 3.29x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Astrazeneca Finance Limited Overview
Astrazeneca Finance Limited is a live company located in cambridge, CB2 0AA with a Companies House number of 02761796. It operates in the banks sector, SIC Code 64191. Founded in October 1992, it's largest shareholder is astrazeneca uk ltd with a 100% stake. Astrazeneca Finance Limited is a mature, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Astrazeneca Finance Limited Health Check
There is insufficient data available to calculate a health check for Astrazeneca Finance Limited. Company Health Check FAQs
0 Strong
0 Regular
0 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Astrazeneca Finance Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Astrazeneca Finance Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- Astrazeneca Finance Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- Astrazeneca Finance Limited
- - Industry AVG
Employees
There is insufficient data available for this Key Performance Indicator!
- - Astrazeneca Finance Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Astrazeneca Finance Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Astrazeneca Finance Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Astrazeneca Finance Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Astrazeneca Finance Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Astrazeneca Finance Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Astrazeneca Finance Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Astrazeneca Finance Limited
- - Industry AVG
ASTRAZENECA FINANCE LIMITED financials
Astrazeneca Finance Limited's latest turnover from December 2023 is estimated at 0 and the company has net assets of £64.8 thousand. According to their latest financial statements, we estimate that Astrazeneca Finance Limited has no employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||||||||
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | |||||||||||||||
| Interest Receivable | |||||||||||||||
| Pre-Tax Profit | |||||||||||||||
| Tax | |||||||||||||||
| Profit After Tax | |||||||||||||||
| Dividends Paid | |||||||||||||||
| Retained Profit | |||||||||||||||
| Employee Costs | |||||||||||||||
| Number Of Employees | |||||||||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | |||||||||||||||
| Intangible Assets | |||||||||||||||
| Investments & Other | |||||||||||||||
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | |||||||||||||||
| Stock & work in progress | |||||||||||||||
| Trade Debtors | |||||||||||||||
| Group Debtors | 64,822 | 64,822 | 64,822 | 64,822 | 64,822 | ||||||||||
| Misc Debtors | |||||||||||||||
| Cash | |||||||||||||||
| misc current assets | |||||||||||||||
| total current assets | 64,822 | 64,822 | 64,822 | 64,822 | 64,822 | ||||||||||
| total assets | 64,822 | 64,822 | 64,822 | 64,822 | 64,822 | ||||||||||
| Bank overdraft | |||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | |||||||||||||||
| Group/Directors Accounts | |||||||||||||||
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | |||||||||||||||
| total current liabilities | |||||||||||||||
| loans | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | |||||||||||||||
| total long term liabilities | |||||||||||||||
| total liabilities | |||||||||||||||
| net assets | 64,822 | 64,822 | 64,822 | 64,822 | 64,822 | ||||||||||
| total shareholders funds | 64,822 | 64,822 | 64,822 | 64,822 | 64,822 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | |||||||||||||||
| Amortisation | |||||||||||||||
| Tax | |||||||||||||||
| Stock | |||||||||||||||
| Debtors | 64,822 | ||||||||||||||
| Creditors | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| Deferred Taxes & Provisions | |||||||||||||||
| Cash flow from operations | |||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | |||||||||||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | |||||||||||||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | |||||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | |||||||||||||||
| cash flow from financing | |||||||||||||||
| cash and cash equivalents | |||||||||||||||
| cash | |||||||||||||||
| overdraft | |||||||||||||||
| change in cash |
astrazeneca finance limited Credit Report and Business Information
Astrazeneca Finance Limited Competitor Analysis
Perform a competitor analysis for astrazeneca finance limited by selecting its closest rivals, whether from the FINANCIAL AND INSURANCE ACTIVITIES sector, other mature companies, companies in CB2 area or any other competitors across 12 key performance metrics.
astrazeneca finance limited Ownership
ASTRAZENECA FINANCE LIMITED group structure
Astrazeneca Finance Limited has no subsidiary companies.
Ultimate parent company
2 parents
ASTRAZENECA FINANCE LIMITED
02761796
astrazeneca finance limited directors
Astrazeneca Finance Limited currently has 3 directors. The longest serving directors include Mr Adrian Kemp (Jan 2009) and Mr Iain Collins (May 2017).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Adrian Kemp | United Kingdom | 58 years | Jan 2009 | - | Director |
| Mr Iain Collins | United Kingdom | 54 years | May 2017 | - | Director |
| Mr Matthew Bowden | United Kingdom | 47 years | Feb 2019 | - | Director |
P&L
December 2023turnover
0
0%
operating profit
0
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
64.8k
0%
total assets
64.8k
0%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
astrazeneca finance limited company details
company number
02761796
Type
Private limited with Share Capital
industry
64191 - Banks
82990 - Other business support service activities n.e.c.
incorporation date
October 1992
age
33
incorporated
UK
ultimate parent company
accounts
Dormant
last accounts submitted
December 2023
previous names
zeneca finance limited (August 2000)
biomonde limited (November 1992)
accountant
-
auditor
-
address
1 francis crick avenue, cambridge biomedical campus, cambridge, CB2 0AA
Bank
-
Legal Advisor
-
astrazeneca finance limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to astrazeneca finance limited.
astrazeneca finance limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ASTRAZENECA FINANCE LIMITED. This can take several minutes, an email will notify you when this has completed.
astrazeneca finance limited Companies House Filings - See Documents
| date | description | view/download |
|---|
